Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (10)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Okamoto, T.
Right arrow Articles by Osawa, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Okamoto, T.
Right arrow Articles by Osawa, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Molecular Human Reproduction, Vol. 8, No. 4, 392-398, April 2002
© 2002 European Society of Human Reproduction and Embryology


Implantation and pregnancy

Reduced expression of tissue inhibitor of metalloproteinase (TIMP)-2 in gestational trophoblastic diseases

Tomomitsu Okamoto1,3, Rong Niu2, Satoru Yamada1 and Masami Osawa1

1 Department of Obstetrics and Gynaecology, Chukyo Hospital 2 Department of Obstetrics and Gynaecology, Nagoya University School of Medicine, Nagoya, Japan

To elucidate the involvement of type IV collagenases [matrix metalloproteinase (MMP)-2 and MMP-9] and their tissue inhibitors (TIMP-1 and TIMP-2) in the development of gestational trophoblastic disease (GTD), we quantified their levels in hydatidiform mole and choriocarcinoma tissues using specific enzyme-linked immunosorbent assays, and the results were compared with those from normal first trimester placenta. Levels of pro-MMP-2 were increased in hydatidiform mole, and they were further elevated in choriocarcinoma. Levels of pro-MMP-9 in choriocarcinoma and those of TIMP-1 in both hydatidiform mole and choriocarcinoma were also increased. In contrast, TIMP-2 levels were markedly decreased in both hydatidiform mole and choriocarcinoma. Similar results were obtained by the tissue culture of first trimester placenta and hydatidiform mole. Gelatin zymography indicated that the levels of both pro- and activated forms of MMP-2 and MMP-9 were higher in hydatidiform mole and choriocarcinoma. The decreased expression of TIMP-2 in hydatidiform mole and choriocarcinoma was confirmed by Western blot, Northern blot and immunohistochemistry, with the decrease being more pronounced in choriocarcinoma. Taken together, the present study shows that both TIMP-2 mRNA and protein levels are markedly decreased in GTD and the imbalance of MMP–TIMP production, shifted toward greater MMP activity, may be involved in the pathogenesis of GTD.

choriocarcinoma/hydatidiform mole/MMP/TIMP/trophoblastic disease

3 To whom correspondence should be addressed at: Department of Obstetrics and Gynaecology, Chukyo Hospital, 1-1-10, Sanjo, Minami-ku, Nagoya 457-8510, Japan. E-mail: kmottm8{at}hotmail.com


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
S. B. Lee, A. P. Wong, K. Kanasaki, Y. Xu, V. K. Shenoy, T. F. McElrath, G. M. Whitesides, and R. Kalluri
Preeclampsia: 2-Methoxyestradiol Induces Cytotrophoblast Invasion and Vascular Development Specifically under Hypoxic Conditions
Am. J. Pathol., February 1, 2010; 176(2): 710 - 720.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
P M Chiu, H C Feng, D M Benbrook, H Y S Ngan, U S Khoo, W C Xue, S W Tsao, K W Chan, and A N Y Cheung
Effect of all-trans retinoic acid on tissue dynamics of choriocarcinoma cell lines: an organotypic model
J. Clin. Pathol., August 1, 2006; 59(8): 845 - 850.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
T. Okamoto, R. Niu, and S. Yamada
Increased expression of tissue inhibitor of metalloproteinase-2 in clear cell carcinoma of the ovary
Mol. Hum. Reprod., October 1, 2003; 9(10): 569 - 575.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.